{
    "nctId": "NCT02920177",
    "officialTitle": "Platelet-rich Plasma Versus Corticosteroid Injection for the Treatment of Femoroacetabular Impingement",
    "inclusionCriteria": "* Patients with symptomatic FAI\n* Clinical and radiographic evidence of FAI\n* Patients able to provide consent to study participation\n* Completion of 6 weeks of physical therapy program\n* Must have minimum age of 18 Years\n* Must have maximum age of 45 Years",
    "exclusionCriteria": "* Established Osteoarthritis (Kellgren-Lawrence \\> 3)\n* Minimum joint space \\> 2 mm as measured on AP radiograph\n* Hip dysplasia (center edge angle \\< 20\u00b0 on AP radiograph)\n* Patients with clinically significant cardiovascular, renal, hepatic, endocrine disease, cancer or diabetes\n* Patients with ongoing infection including HIV and Hepatitis\n* Patient with history of osteomyelitis/septic arthritis\n* Anticoagulation therapy\n* Patients who are pregnant or breast feeding\n* Patients with systemic, rheumatic or inflammatory disease of the knee or chondrocalcinosis, hemochromatosis, inflammatory arthritis, arthropathy of the knee associated with juxta-articular Paget's disease of the femur or tibia, hemophilic arthropathy, infectious arthritis, Charcot's knee joint, villonodular synovitis, and synovial chondromatosis\n* Patients taking immunosuppressant medication\n* Patients with abnormal hematology or serum chemistry lab results\n* Patients receiving injection to treatment knee within 2 months of study enrollment\n* BMI greater than 35 or less than 20"
}